Panobinostat
CAS 404950-80-7Small Molecule
Overview
Panobinostat is a potent pan-deacetylase inhibitor with activity against multiple myeloma and other hematological malignancies. It is specifically designed to inhibit the enzymatic activity of histone deacetylases (HDACs), potentially resulting in cell cycle arrest and apoptosis of cancer cells.
Therapeutic areas
OncologyHematology
Verified Supplier Partner
Do you supply Panobinostat? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.